Article Per Year (5 Year)
p-Index From 2021 - 2026
0
P-Index
This Author published in this journals
All Journal Jurnal Farmasi Udayana
Rini Meliawati
Unknown Affiliation
Medicine & Pharmacology

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
Kebijakan Industri Farmasi pada Masa Pandemi COVID-19 Rini Meliawati
Jurnal Farmasi Udayana Vol. 9, No. 2, Tahun 2020
Publisher : Departement of Pharmacy, Faculty of Mathematics and Natural Science, Udayana University

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24843/JFU.2020.v09.i02.p02

Abstract

Drug shortages has been global problem since 2000s until now, and it become in serious condition by the presence of the pandemic COVID-19. The main causes of drug shortages were economic and regulation, business problem, manufacture and supply chain. During this pandemic, the main causes of drug shortages are many pharmaceutical industries closures due to quarantine, logistical problems caused by border closure, export bans, quarantine of exporting active subtances and drugs’countries, increased demand and pilling up. However, this problem has been overcome by making policies and good cooperation between governments, regulatory institution and the pharmaceutical industry throughout the world. Several policies like increasing production capacity, restrict quantity of drugs purchased by the public, facilitate the process of industrial license and making a systems such as i-SPOC (Industry Single Point of Contact). It is expected to reduce drugs shortages problem during this pandemic.
Co-Authors